These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7658327)

  • 1. Recombinant human erythropoietin and parenteral iron in the treatment of pregnancy anemia: a pilot study.
    Breymann C; Major A; Richter C; Huch R; Huch A
    J Perinat Med; 1995; 23(1-2):89-98. PubMed ID: 7658327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy.
    Breymann C; Fibach E; Visca E; Huettner C; Huch A; Huch R
    J Matern Fetal Med; 1999; 8(1):1-7. PubMed ID: 10052837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of recombinant human erythropoietin in combination with parenteral iron in the treatment of postpartum anaemia.
    Breymann C; Zimmermann R; Huch R; Huch A
    Eur J Clin Invest; 1996 Feb; 26(2):123-30. PubMed ID: 8904521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin in the treatment of iron deficiency anemia during pregnancy.
    Sifakis S; Angelakis E; Vardaki E; Koumantaki Y; Matalliotakis I; Koumantakis E
    Gynecol Obstet Invest; 2001; 51(3):150-6. PubMed ID: 11306899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Review by expert group in the diagnosis and treatment of anemia in pregnant women. Federación Mexicana de Colegios de Obstetricia y Ginecología].
    Montoya Romero Jde J; Castelazo Morales E; Valerio Castro E; Velázquez Cornejo G; Nava Muñoz DA; Escárcega Preciado JA; Montoya Cossío J; Pichardo Villalón GM; Maldonado Aragón A; Santana García HR; Fajardo Dueñas S; Mondragón Galindo CG; García Lee T; García A; Hernández de Morán M; Chávez Güitrón LE; Jiménez Gutiérrez C;
    Ginecol Obstet Mex; 2012 Sep; 80(9):563-80. PubMed ID: 23243836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. rhEPO treatment of postpartum anemia.
    Zimmermann R; Breymann C; Richter C; Huch R; Huch A
    J Perinat Med; 1995; 23(1-2):111-7. PubMed ID: 7658310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery.
    Madi-Jebara SN; Sleilaty GS; Achouh PE; Yazigi AG; Haddad FA; Hayek GM; Antakly MC; Jebara VA
    J Cardiothorac Vasc Anesth; 2004 Feb; 18(1):59-63. PubMed ID: 14973801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron status markers and serum erythropoietin in 120 mothers and newborn infants. Effect of iron supplementation in normal pregnancy.
    Milman N; Agger AO; Nielsen OJ
    Acta Obstet Gynecol Scand; 1994 Mar; 73(3):200-4. PubMed ID: 8122498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy.
    Bhandari S; Norfolk D; Brownjohn A; Turney J
    Am J Kidney Dis; 1997 Dec; 30(6):814-21. PubMed ID: 9398126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy.
    Biesma DH; Van de Wiel A; Beguin Y; Kraaijenhagen RJ; Marx JJ
    Eur J Clin Invest; 1994 Jun; 24(6):426-32. PubMed ID: 7957497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK; Morgenstern T
    Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current recommendations for the treatment of iron deficiency anemia].
    Schaefer RM; Huch R; Krafft A;
    Rev Med Suisse; 2007 Apr; 3(105):874-80. PubMed ID: 17514929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
    Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
    J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of hemoglobin, serum ferritin, and serum transferrin receptor during iron supplementation in pregnancy: a prospective study.
    Madhavan Nair K; Bhaskaram P; Balakrishna N; Ravinder P; Sesikeran B
    Nutrition; 2004 Oct; 20(10):896-9. PubMed ID: 15474878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross sectional, comparative study of serum erythropoietin, transferrin receptor, ferritin levels and other hematological indices in normal pregnancies and iron deficiency anemia during pregnancy.
    Sharma JB; Bumma SD; Saxena R; Kumar S; Roy KK; Singh N; Vanamail P
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():99-103. PubMed ID: 27267870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency.
    Gasché C; Reinisch W; Lochs H; Parsaei B; Bakos S; Wyatt J; Fueger GF; Gangl A
    Dig Dis Sci; 1994 Sep; 39(9):1930-4. PubMed ID: 8082499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
    Arndt U; Kaltwasser JP; Gottschalk R; Hoelzer D; Möller B
    Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study.
    Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S
    Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal timing of repeated rh-erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers.
    Breymann C; Bauer C; Major A; Zimmermann R; Gautschi K; Huch A; Huch R
    Br J Haematol; 1996 Feb; 92(2):295-301. PubMed ID: 8602988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.